title: Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1?
authors.forename: Frank Z
authors.initials: FZ
authors.lastname: Stanczyk
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D003271:Contraceptive Agents, Female / Q000494:pharmacology*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology*; D008565:Membrane Proteins / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D003271:Contraceptive Agents, Female; D008565:Membrane Proteins; C115296:PGRMC1 protein, human; D011980:Receptors, Progesterone; D000077267:Fulvestrant; D004958:Estradiol; D017258:Medroxyprogesterone Acetate